These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5127971)

  • 1. Vasoconstrictor potency of corticoids: intradermal injection.
    Sutton PM; Feldmann RJ; Maibach HI
    J Invest Dermatol; 1971 Dec; 57(6):371-6. PubMed ID: 5127971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Practical importance and the criteria of value of external corticoids].
    Weirich EG
    Wien Med Wochenschr; 1966 Aug; 116(32):665-73. PubMed ID: 5995274
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium-lowering action of glucocorticoids in adrenalectomized-parathyroidectomized rats. Specificity and relative potency of natural and synthetic glucocorticoids.
    Mahgoub A; Hirsch PF; Munson PL
    Endocrine; 1997 Jun; 6(3):279-83. PubMed ID: 9368684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoconstrictor and systemic activities of topical steroids.
    Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
    Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
    [No Abstract]   [Full Text] [Related]  

  • 5. Stabilising action of anti-inflammatory steroids on lysosomes.
    Symons AM; Lewis DA; Ancill RJ
    Biochem Pharmacol; 1969 Oct; 18(10):2581-2. PubMed ID: 5403994
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of corticosteroids on human epidermal mitotic activity.
    Fisher LB; Maibach HI
    Arch Dermatol; 1971 Jan; 103(1):39-44. PubMed ID: 4321801
    [No Abstract]   [Full Text] [Related]  

  • 7. A specific effect of glucocorticoids in decreasing neutral ribonuclease II in skeletal muscle.
    Kershner RM; Meyer WL
    Biochem Biophys Res Commun; 1976 May; 70(2):513-8. PubMed ID: 938507
    [No Abstract]   [Full Text] [Related]  

  • 8. [Remarks on the percutaneous absorption of corticoids].
    Rimbaud P; Meynadier J
    Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative changes in the function of muscle ribosomes and mitochondria during the early phase of steroid-induced catabolism.
    Bullock GR; Carter EE; Elliott P; Peters RF; Simpson P; White AM
    Biochem J; 1972 May; 127(5):881-92. PubMed ID: 5076236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is the vasoconstrictor test suitable for comparing the effect of locally applied corticosteroids? An experimental study].
    Zaun H
    Arch Klin Exp Dermatol; 1966; 226(4):359-68. PubMed ID: 5987407
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucocorticoids for parenteral administration.
    Med Lett Drugs Ther; 1965 Dec; 7(27):111-2. PubMed ID: 4285249
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

  • 13. The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation.
    Ishikawa H; Mori Y; Tsurufuji S
    Eur J Pharmacol; 1969 Aug; 7(2):201-5. PubMed ID: 5345995
    [No Abstract]   [Full Text] [Related]  

  • 14. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
    Poulsen BJ; Burdick K; Bessler S
    Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of atrophy production and vasoconstrictor potency in humans following intradermally injected corticosteroids.
    Snyder DS; Greenberg RA
    J Invest Dermatol; 1974 Dec; 63(6):461-3. PubMed ID: 4430856
    [No Abstract]   [Full Text] [Related]  

  • 16. Depression of 3 H-glucose uptake into rabbit polymorphonuclear leukocytes by glucocorticoids in concentrations partly saturating the specific glucocorticoid uptake. Evidence for a glucocorticoid receptor.
    Simonsson B
    Acta Physiol Scand; 1972 Nov; 86(3):398-409. PubMed ID: 4638702
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of the mechanisms by which cells become resistant to corticosteroids.
    Berliner DL
    Cancer Res; 1965 Aug; 25(7):1085-95. PubMed ID: 5214994
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological action of corticoids].
    Neidhardt A
    Anesth Analg (Paris); 1969; 26(5):711-22. PubMed ID: 5368576
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacology of dermatocorticoids (2. Continuation)].
    Weirich EG
    Z Hautkr; 1978 Apr; 53(7):209-16 contd. PubMed ID: 645170
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibitory action of glucocorticoids on glucose-6-phosphate dehydrogenase activty. A screening of antipsoriatic effects (author's transl)].
    Raab W; Siber H
    Arch Dermatol Forsch; 1974 Jun; 249(4):357-66. PubMed ID: 4407433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.